April 17 (UPI) --People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following ... an already approved migraine drug that can stop symptoms ...

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk (NYSE: NVO )’s Wegovy across five ...

Eli Lilly, the drugmaker behind the blockbuster weight loss drug ... never been approved by the FDA. "Fella even tells patients that its untested oral drug is better than Lilly's approved ...

Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound ... Today in History: May 16, China’s Cultural Revolution begins ...

Eli Lilly (NYSE ... although it was approved only in late 2023. Zepbound's prospects still look bright, but some recent developments point to another weight loss drug that could become yet ...

Eli Lilly, the drugmaker behind the blockbuster weight loss ... available drug. Mochi representatives did not respond to requests for comment. Lilly's complaint against Henry Meds alleges the ...